Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors

Early Human Development

Volumn 89, Issue 2, 2013, Pages 81-86

  Smith, Megan V ^a,b,c   Sung, Anita ^c   Shah, Bhavesh ^d   Mayes, Linda ^b   Klein, Deborah S ^d   Yonkers, Kimberly A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

^d BAYSTATE MEDICAL CENTER   (United States)

Author keywords

Perinatal depression; Selective serotonin reuptake inhibitors

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADULT; APGAR SCORE; ARTICLE; BIRTH WEIGHT; BRAZELTON NEONATAL BEHAVIORAL ASSESSMENT SCALE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HUMAN; INFANT; MEAN GESTATIONAL AGE; MEDICAL RECORD REVIEW; MOTOR ACTIVITY; MOTOR DEVELOPMENT; NEWBORN MONITORING; PRENATAL DRUG EXPOSURE; SIDE EFFECT; SLEEP; SLEEP WAKING CYCLE; STARTLE REFLEX; TEMPERAMENT; THIRD TRIMESTER PREGNANCY; TREMOR; WAKEFULNESS;

ANTIDEPRESSIVE AGENTS; CHILD DEVELOPMENT; DEPRESSION; FEMALE; HUMANS; INFANT BEHAVIOR; INFANT, NEWBORN; MALE; MOTOR ACTIVITY; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; SLEEP;

EID: 84871968485     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2012.08.001     Document Type: Article

References (26)

1. Cooper W.O., Willy M.E., Pont S.J., Ray W.A. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 2007, 196(6):544.e1.
2. Laine K., Heikkinen T., Ekblad U., Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 2003, 60:720-726.
3. Zeskind P., Stephens L. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004, 113(2):368-375.
4. Costei A., Kozer E., Ho T., Ito S., Koren G. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002, 156:1129-1132.
5. Sanz E., De-las-Cuevas C., Kiuru A., Bate A., Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005, 365:482-487.
6. Boucher N., Bairam A., Beaulac-Baillargeon L. A new look at the neonate's clinical presentation after in utero exposure to antidepressants in late pregnancy. J Clin Psychopharmacol 2008, 28(3):334-339.
7. Gentile S. On categorizing gestational birth, and neonatal complications following late pregnancy exposure to antidepressants: the prenatal antidepressant exposure syndrome. CNS Spectr 2010, 15(3):167-185.
8. Casper R.C., Fleisher B.E., Lee-Ancajas J., Gilles A., Gaylor E., DeBattista A., et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003, 142:402-408.
9. Ferreira E., Carceller A.M., Agogue C., Martin B.Z., St-Andre M., Francoeur D., et al. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics 2007, 119(1):52-59.
10. Levinson-Castiel R., Merlob P., Linder N., Sirota L., Klinger G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006, 160:173-176.
11. Suri R., Altshuler L., Hellemann G., Burt V.K., Aquino A., Mintz J. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 2007, 164(8):1206-1213.
12. Wisner K.L., Sit D.K., Hanusa B.H., Moses-Kolko E.L., Bogen D.L., Hunker D.F., et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry 2009, 166(5):557-566.
13. Oberlander T.F., Warburton W., Misri S., Aghajanian J., Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006, 63(8):898-906.
14. Wittchen H.-U. Reliability and validity studies of the WHO Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994, 28:57-84.
15. Sheehan D., Lecrubier Y., Sheehan K., Amorim P., Janava J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(S20):22-33.
16. Cox J.L., Holden J.M., Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987, 150:782-786.
17. Brazelton T., Nugent J. Neonatal Behavioral Assessment Scale 1995, Cambridge University Press, London. 3rd ed.
18. Lester B., Als H., Brazelton T. Regional obstetric anesthesia and newborn behavior: a reanalysis toward synergistic effects. Child Dev 1982, 53:687-692.
19. Oberlander T., Gingrich J., Ansorge M. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharmacol Ther 2009, 86(6):672-677.
20. Bairy K., Madhyastha S., Ashok K., Bairy I., Malini S. Developmental and behavioral consequences of prenatal fluoxetine. Pharmacology 2007, 79:1-11.
21. Pedersen L., Henriksen T., Olsen J. Fetal exposure to antidepressants and normal milestone development at 6 and 19months of age. Pediatrics 2010, 125:e600-e608.
22. Oberlander T.F., Bonaguro R.J., Misri S., Papsdorf M., Ross C.J.D., Simpson E.M. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications. Mol Psychiatry 2008, 13(1):65-73.
23. College of Obstetricians and Gynecologists and Committee on Obstetric Practice American Academy of Pediatrics CoFaN, American The APGAR score. Pediatrics 2006, 117(4):1144-1447
24. Institute of Medicine Preterm birth: causes, consequences, and prevention 2006, National Academies Press, Washington, D.C.
25. Stiskal J., Kulin N., Koren G., Ho T., Ito S. Neonatal paroxetine withdrawal syndrome. Arch Dis Child Fetal Neonatal Ed 2001, 84:F134-F135.
26. Dahl M., Olhager E., Ahlner J. Paroxetine withdrawal syndrome in a neonate. Br J Psychiatry 1997, 171:391-392.